Oral Presentation

A Longitudinal Multidimensional Rehabilitation Program for Patients Undergoing Allogeneic Blood and Marrow Transplantation (CaRE-4-alloBMT): A Phase II Feasibility Pilot Randomized Controlled Trial

Presenting Author(s)

• 

  Jennifer M. Jones, PhD

  Director and Senior Scientist, Cancer Rehabilitation and Survivorship
  Princess Margaret Cancer Centre/Univerity of Toronto
  Toronto, Ontario, Canada

  Slides Slides

Non-presenting Author(s)

• ST

  Samantha Tam, MSc (c)

  Master's student
  Princess Margaret Cancer Centre, University Health Network, United States
• RK

  Rajat Kumar, MD

  Head of Malignant Hematology
  Princess Margaret Cancer Centre, UHN, United States
• PL

  Paty Lopez, MSc, RKin

  Registered kinesiologist
  Princess Margaret Cancer Centre, UHN, United States
• JM

  Jonas Mattsson, MD, PhD

  Director, Hans Messner Allogeneic Transplant Program.
  Princess Margaret Cancer Centre, UHN, United States
• SA

  Shabbir Alibhai, MSc, MD

  Staff physician (geriatrics) and senior scientist
  Princess Margaret Cancer Centre, UHN, United States
• LB

  Lori J. Bernstein, PhD, CPsych.

  Neuropsychologist
  Princess Margaret Cancer Centre
  Toronto, Ontario, Canada
• 

  Eugene K. Chang, MD

  Physiatrist
  University Health Network
  Toronto, Ontario, United States
• 

  David Michael Langelier, MSc, MD

  Physiatrist and Clinician Investigator
  University Health Network
  Toronto, Ontario, Canada